Udenafil test during exercise for teens with Fontan circulation
Part of Heart & circulation clinical trials.
This trial tests whether udenafil helps teens and young people with Fontan circulation do better on exercise and breathing-related measures over time. You’d need to be on blood-thinning medicine, and be able to complete exercise testing safely.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 12 to under 19 with Fontan circulation
- You and/or your parent/guardian can consent, and you agree to participate
- You can speak and understand the main study language where you live
- You are currently taking a blood thinner or antiplatelet medicine
- You are at least 132 cm tall and at least 40 kg
- You must be able to complete the exercise test fully
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a medication called dapagliflozin (a pill for heart failure) can help people with a Fontan circulation who feel short of breath. It aims to improve symptoms and quality of life.
This study tests whether a home-based exercise training program can improve fitness in people with Fontan circulation. Participants will do regular aerobic exercise and be monitored for changes in heart and lung function over time.
This trial studies how the drugs sildenafil and pravastatin work in people with a single ventricle heart condition who have had the Fontan surgery and may have related liver problems. The goal is to find the best doses based on liver function.
This study looks at whether placing a stent in the Fontan blood vessel can improve liver health and exercise ability in teenagers and young adults. If you are between 12 and 21 years old and need a stent in your Fontan pathway, you may be able to join.
This trial tests if a supervised exercise program (cardiac rehabilitation) can help people who have had a Fontan procedure and are now experiencing heart failure symptoms. It aims to improve your strength, stamina, and overall well-being.
This study looks at how well blood flow is regulated in people with HFpEF, a type of heart failure where the heart squeezes normally but doesn’t fill properly. It may help researchers understand the cause of symptoms and how to improve treatment strategies.
Hear when a new Single Ventricle Heart Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.